The Kaplan–Meier survival analysis revealed a significant association between high AFAP1‐AS1 expression and poorer overall survival (OS) and disease‐free survival (DFS) in breast cancer patients, compared to those with low expression levels (p < 0.001, Figure 3A,B). Here, AFAP1 is linked to breast carcinoma.